糖尿病与房颤所致缺血性卒中全球负担趋势对比
基于全球疾病负担2021数据,分析房颤相关与糖尿病相关缺血性卒中的负担趋势。
要点
- 房颤相关缺血性卒中年龄标化发病率呈下降趋势,糖尿病相关则持续上升。
- 中高社会人口指数地区承受两类卒中的最大负担。
- 高体重指数是房颤、糖尿病和缺血性卒中的共同关键风险因素。
核心结论
- 缺血性卒中仍是全球重大健康挑战,主要驱动因素为糖尿病相关负担上升。
- 需针对年龄和国家制定特异性干预措施。
研究设计与样本
- 基于全球疾病负担2021数据的分析研究,采用人群归因分数评估房颤和糖尿病相关缺血性卒中的负担。
- 按时间、地点和年龄组分层计算人群归因分数,并使用Joinpoint回归和时间序列预测至2050年。
主要发现
- 1990年房颤相关缺血性卒中年龄标化发病率较高但稳步下降,平均年度百分比变化为-0.81(95%CI -0.92至-0.69)。
- 糖尿病相关缺血性卒中初始发病率较低但持续大幅上升,平均年度百分比变化为1.10(95%CI 1.02至1.18)。
- 北美和东欧房颤相关缺血性卒中年龄标化发病率趋稳(AAPC分别为-1.45和-0.95),而糖尿病相关则持续增加(AAPC分别为1.18和0.72)。
- 中高社会人口指数地区承受两类卒中的最大负担。
- 高体重指数是房颤、糖尿病和缺血性卒中的共同关键风险因素。
关键数值与推荐
- 房颤相关缺血性卒中全球年龄标化发病率平均年度百分比变化为-0.81(95%CI -0.92至-0.69)。
- 糖尿病相关缺血性卒中全球年龄标化发病率平均年度百分比变化为1.10(95%CI 1.02至1.18)。
- 北美房颤相关缺血性卒中年龄标化发病率平均年度百分比变化为-1.45(95%CI -1.63至-1.27)。
- 东欧房颤相关缺血性卒中年龄标化发病率平均年度百分比变化为-0.95(95%CI -1.06至-0.84)。
- 北美和东欧糖尿病相关缺血性卒中年龄标化发病率平均年度百分比变化分别为1.18(95%CI 1.02至1.34)和0.72(95%CI 0.56至0.88)。
临床怎么用
- 临床应关注糖尿病相关缺血性卒中的持续上升趋势,加强糖尿病患者的卒中预防。
- 针对高体重指数等共同风险因素进行综合管理,可能同时降低房颤、糖尿病和卒中风险。
- 根据年龄和国家差异制定针对性干预策略。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemic stroke (IS) related to atrial fibrillation (AF) represents a cardio-cerebral comorbidity, whereas diabetes-related IS reflects an advanced manifestation of panvascular disease. We aimed to analyze the burden trends in AF-related and diabetes-related IS, using Global Burden of Diseases 2021 data. METHODS: To quantify the burdens of AF- and diabetes-related IS, we applied the population-attributable fraction, the proportion of burden preventable by eliminating a risk factor. We calculated population-attributable fractions stratified by time, location, and age group. We analyzed the burdens using joinpoint regression, time-series projection to 2050, and age/sex-stratified. RESULTS: Globally, AF-related IS had a higher age-standardized incidence rate in 1990 but declined steadily (average annual percentage change =-0.81 [95% CI, -0.92 to -0.69]). Conversely, diabetes-related IS, despite a lower initial incidence, exhibited substantial and sustained increases (average annual percentage change=1.10 [95% CI, 1.02-1.18]). Middle-high socio-demographic index regions experienced the greatest burden from both comorbidities. In North America and Eastern Europe, the age-standardized incidence rates of AF-related IS stabilized (average annual percentage change=-1.45 [95% CI, -1.63 to -1.27]; -0.95 [95% CI, -1.06 to -0.84]), whereas the age-standardized incidence rates of diabetes-related IS continued to increase (average annual percentage change=1.18 [95% CI, 1.02-1.34]; 0.72 [95% CI, 0.56-0.88]). High body mass index emerged as a critical shared risk factor for AF, diabetes, and IS. Projections indicate a substantial increase in diabetes-related IS incidence over the next 3 decades, contrasting with minimal growth in AF-related IS. CONCLUSIONS: IS remains a critical global health challenge, primarily driven by the rising burden of diabetes-related IS. Our findings highlight the importance of age- and country-specific interventions.
引用
- Wang L, Lin F, Chen Y, et al. Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation. Stroke. 2026. PMID: 42464804. doi:10.1161/STROKEAHA.125.054141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。